MiR-29c is downregulated in the ectopic endometrium and exerts its effects on endometrial cell proliferation, apoptosis and invasion by targeting c-Jun

International Journal of Molecular Medicine

Volumn 35, Issue 4, 2015, Pages 1119-1125

  Long, Mei ^a   Wan, Xiaohui ^a   La, Xiaolin ^a   Gong, Xiaoyun ^a   Cai, Xia ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

C Jun; Endometriosis; MiR 29c

Indexed keywords

MICRORNA 29; MICRORNA 29A; MICRORNA 29B; MICRORNA 29C; PROTEIN C JUN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; MICRORNA; MIRN29 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ADULT; APOPTOSIS; ARTICLE; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOMETRIOSIS; ENDOMETRIUM CELL; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUCIFERASE ASSAY; MTT ASSAY; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WILD TYPE; CELL LINE; CELL MOTION; CHEMISTRY; ENDOMETRIUM; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

APOPTOSIS; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; PROTO-ONCOGENE PROTEINS C-JUN; TRANSFECTION;

EID: 84923675289     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2015.2082     Document Type: Article

References (28)

1. Giudice LC: Clinical practice. Endometriosis. N Engl J Med 362: 2389-2398, 2010.
2. Painter JN, Anderson CA, Nyholt DR, et al: Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis. Nat Genet 43: 51-54, 2011.
3. Simpson JL, Elias S, Malinak LR and Buttram VC Jr: Heritable aspects of endometriosis. I. Genetic studies. Am J Obstet Gynecol 137: 327-331, 1980.
4. Anger DL and Foster WG: The link between environmental toxicant exposure and endometriosis. Front Biosci 13: 1578-1593, 2008.
5. Corwin EJ: Endometriosis: pathophysiology, diagnosis, and treatment. Nurse Pract 22: 35-8, 40-42, 45-46, passim; quiz 56-57, 1997.
6. Miska EA: How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 15: 563-568, 2005.
7. Jannot G and Simard MJ: Tumour-related microRNAs functions in Caenorhabditis elegans. Oncogene 25: 6197-6201, 2006.
8. Vandenboom Ii TG, Li Y, Philip PA and Sarkar FH: MicroRNA and cancer: tiny molecules with major implications. Curr Genomics 9: 97-109, 2008.
9. Segura MF, Hanniford D, Menendez S, et al: Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci USA 106: 1814-1819, 2009.
10. Gaetje R, Kotzian S, Herrmann G, Baumann R and Starzinski-Powitz A: Invasiveness of endometriotic cells in vitro. Lancet 346: 1463-1464, 1995.
11. Pan Q, Luo X, Toloubeydokhti T and Chegini N: The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod 13: 797-806, 2007.
12. Ohlsson Teague EM, Van der Hoek KH, Van der Hoek MB, et al: MicroRNA-regulated pathways associated with endometriosis. Mol Endocrinol 23: 265-275, 2009.
13. Gong J, Li J, Wang Y, et al: Characterization of microRNA-29 family expression and investigation of their mechanistic roles in gastric cancer. Carcinogenesis 35: 497-506, 2014.
14. Fan YC, Mei PJ, Chen C, Miao FA, Zhang H and Li ZL: MiR-29c inhibits glioma cell proliferation, migration, invasion and angiogenesis. J Neurooncol 115: 179-188, 2013.
15. Nygren MK, Tekle C, Ingebrigtsen VA, et al: Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c. Br J Cancer 110: 2072-2080, 2014.
16. Bae HJ, Noh JH, Kim JK, et al: MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma. Oncogene 33: 2557-2567, 2014.
17. Meola J, Rosa e Silva JC, Dentillo DB, et al: Differentially expressed genes in eutopic and ectopic endometrium of women with endometriosis. Fertil Steril 93: 1750-1773, 2010.
18. Honda H, Barrueto FF, Gogusev J, Im DD and Morin PJ: Serial analysis of gene expression reveals differential expression between endometriosis and normal endometrium. Possible roles for AXL and SHC1 in the pathogenesis of endometriosis. Reprod Biol Endocrinol 6: 59, 2008.
19. Hu WP, Tay SK and Zhao Y: Endometriosis-specific genes identified by real-time reverse transcription-polymerase chain reaction expression profiling of endometriosis versus autologous uterine endometrium. J Clin Endocrinol Metab 91: 228-238, 2006.
20. Wu Y, Kajdacsy-Balla A, Strawn E, et al: Transcriptional characterizations of differences between eutopic and ectopic endometrium. Endocrinology 147: 232-246, 2006.
21. Eyster KM, Klinkova O, Kennedy V and Hansen KA: Whole genome deoxyribonucleic acid microarray analysis of gene expression in ectopic versus eutopic endometrium. Fertil Steril 88: 1505-1533, 2007.
22. Hull ML, Escareno CR, Godsland JM, et al: Endometrial-peritoneal interactions during endometriotic lesion establishment. Am J Pathol 173: 700-715, 2008.
23. Karin M, Liu Z and Zandi E: AP-1 function and regulation. Curr Opin Cell Biol 9: 240-246, 1997.
24. Shaulian E and Karin M: AP-1 as a regulator of cell life and death. Nat Cell Biol 4: E131-E136, 2002.
25. Eferl R and Wagner EF: AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868, 2003.
26. Karin M and Gallagher E: From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life 57: 283-295, 2005.
27. Okutomi Y, Shino Y, Komoda F, et al: Survival regulation in pancreatic cancer cells by c-Jun. Int J Oncol 23: 1127-1134, 2003.
28. Neyns B, Katesuwanasing, Vermeij J, et al: Expression of the jun family of genes in human ovarian cancer and normal ovarian surface epithelium. Oncogene 12: 1247-1257, 1996.